United States Factor VIII Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Factor VIII

Revenue, means the sales value of Factor VIII

This report studies sales (consumption) of Factor VIII in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- CSL Ltd. (Australia)

- Grifols S.A (Spain)

- Baxalta Incorporated (U.S.)

- Octapharma AG (Switzerland)

- Kedrion S.p.A (Italy)

- China Biologic Products, Inc. (China)

- Biotest AG (Germany)

- LFB S.A (France)

- Bio Product Laboratory Ltd. (U.K.)

- Sanquin (Netherlands)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Factor VIII in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Factor VIII Market Report 2016

Table of Contents
United States Factor VIII Market Report 2016
1 Factor VIII Overview
1.1 Product Overview and Scope of Factor VIII
1.2 Classification of Factor VIII
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Factor VIII
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Factor VIII (2011-2021)
1.4.1 USA Factor VIII Sales and Growth Rate (2011-2021)
1.4.2 USA Factor VIII Revenue and Growth Rate (2011-2021)
2 USA Factor VIII Competition by Manufacturers
2.1 USA Factor VIII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Factor VIII Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Factor VIII Average Price by Manufactures (2015 and 2016)
2.4 Factor VIII Market Competitive Situation and Trends
2.4.1 Factor VIII Market Concentration Rate
2.4.2 Factor VIII Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Factor VIII Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Factor VIII Sales and Market Share by Type (2011-2016)
3.2 USA Factor VIII Revenue and Market Share by Type (2011-2016)
3.3 USA Factor VIII Price by Type (2011-2016)
3.4 USA Factor VIII Sales Growth Rate by Type (2011-2016)
4 USA Factor VIII Sales (Volume) by Application (2011-2016)
4.1 USA Factor VIII Sales and Market Share by Application (2011-2016)
4.2 USA Factor VIII Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Factor VIII Manufacturers Profiles/Analysis
5.1 CSL Ltd. (Australia)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Factor VIII Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 CSL Ltd. (Australia) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Grifols S.A (Spain)
5.2.2 Factor VIII Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Grifols S.A (Spain) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Baxalta Incorporated (U.S.)
5.3.2 Factor VIII Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Baxalta Incorporated (U.S.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Octapharma AG (Switzerland)
5.4.2 Factor VIII Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Octapharma AG (Switzerland) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Kedrion S.p.A (Italy)
5.5.2 Factor VIII Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Kedrion S.p.A (Italy) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 China Biologic Products, Inc. (China)
5.6.2 Factor VIII Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 China Biologic Products, Inc. (China) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biotest AG (Germany)
5.7.2 Factor VIII Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biotest AG (Germany) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 LFB S.A (France)
5.8.2 Factor VIII Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 LFB S.A (France) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Bio Product Laboratory Ltd. (U.K.)
5.9.2 Factor VIII Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Sanquin (Netherlands)
5.10.2 Factor VIII Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Sanquin (Netherlands) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Factor VIII Manufacturing Cost Analysis
6.1 Factor VIII Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Factor VIII
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Factor VIII Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Factor VIII Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Factor VIII Market Forecast (2016-2021)
10.1 USA Factor VIII Sales, Revenue Forecast (2016-2021)
10.2 USA Factor VIII Sales Forecast by Type (2016-2021)
10.3 USA Factor VIII Sales Forecast by Application (2016-2021)
10.4 Factor VIII Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Factor VIII
Table Classification of Factor VIII
Figure USA Sales Market Share of Factor VIII by Type in 2015
Table Application of Factor VIII
Figure USA Sales Market Share of Factor VIII by Application in 2015
Figure USA Factor VIII Sales and Growth Rate (2011-2021)
Figure USA Factor VIII Revenue and Growth Rate (2011-2021)
Table USA Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table USA Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Factor VIII Sales Share by Manufacturers
Figure 2016 Factor VIII Sales Share by Manufacturers
Table USA Factor VIII Revenue by Manufacturers (2015 and 2016)
Table USA Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Factor VIII Revenue Share by Manufacturers
Table 2016 USA Factor VIII Revenue Share by Manufacturers
Table USA Market Factor VIII Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Factor VIII Average Price of Key Manufacturers in 2015
Figure Factor VIII Market Share of Top 3 Manufacturers
Figure Factor VIII Market Share of Top 5 Manufacturers
Table USA Factor VIII Sales by Type (2011-2016)
Table USA Factor VIII Sales Share by Type (2011-2016)
Figure USA Factor VIII Sales Market Share by Type in 2015
Table USA Factor VIII Revenue and Market Share by Type (2011-2016)
Table USA Factor VIII Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Factor VIII by Type (2011-2016)
Table USA Factor VIII Price by Type (2011-2016)
Figure USA Factor VIII Sales Growth Rate by Type (2011-2016)
Table USA Factor VIII Sales by Application (2011-2016)
Table USA Factor VIII Sales Market Share by Application (2011-2016)
Figure USA Factor VIII Sales Market Share by Application in 2015
Table USA Factor VIII Sales Growth Rate by Application (2011-2016)
Figure USA Factor VIII Sales Growth Rate by Application (2011-2016)
Table CSL Ltd. (Australia) Basic Information List
Table CSL Ltd. (Australia) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Ltd. (Australia) Factor VIII Sales Market Share (2011-2016)
Table Grifols S.A (Spain) Basic Information List
Table Grifols S.A (Spain) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols S.A (Spain) Factor VIII Sales Market Share (2011-2016)
Table Baxalta Incorporated (U.S.) Basic Information List
Table Baxalta Incorporated (U.S.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxalta Incorporated (U.S.) Factor VIII Sales Market Share (2011-2016)
Table Octapharma AG (Switzerland) Basic Information List
Table Octapharma AG (Switzerland) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma AG (Switzerland) Factor VIII Sales Market Share (2011-2016)
Table Kedrion S.p.A (Italy) Basic Information List
Table Kedrion S.p.A (Italy) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion S.p.A (Italy) Factor VIII Sales Market Share (2011-2016)
Table China Biologic Products, Inc. (China) Basic Information List
Table China Biologic Products, Inc. (China) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Products, Inc. (China) Factor VIII Sales Market Share (2011-2016)
Table Biotest AG (Germany) Basic Information List
Table Biotest AG (Germany) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotest AG (Germany) Factor VIII Sales Market Share (2011-2016)
Table LFB S.A (France) Basic Information List
Table LFB S.A (France) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table LFB S.A (France) Factor VIII Sales Market Share (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Basic Information List
Table Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales Market Share (2011-2016)
Table Sanquin (Netherlands) Basic Information List
Table Sanquin (Netherlands) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanquin (Netherlands) Factor VIII Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Factor VIII
Figure Manufacturing Process Analysis of Factor VIII
Figure Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Factor VIII Major Manufacturers in 2015
Table Major Buyers of Factor VIII
Table Distributors/Traders List
Figure USA Factor VIII Production and Growth Rate Forecast (2016-2021)
Figure USA Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Table USA Factor VIII Production Forecast by Type (2016-2021)
Table USA Factor VIII Consumption Forecast by Application (2016-2021)
  • United States Anti-Obesity Prescription Drugs Market Report 2017
    Published: 08-Dec-2017        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Anti-Obesity Prescription Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and......
  • Global In Vitro Diagnostics (IVD) Quality Control Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the global In Vitro Diagnostics (IVD) Quality Control market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of In Vitro Diagnostics (IVD) Quality Control for these regions, from 2012 to 2022 (forecast), covering - United State......
  • Global Cholera Vaccine Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Cholera Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Cholera Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan ......
  • Global Combination Vaccine Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Combination Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japa......
  • Global 2,5-Furandimethanol Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the global 2,5-Furandimethanol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of 2,5-Furandimethanol for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • Global Edible Vaccine Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Edible Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Edible Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • China Sexual Enhancement Supplements Market Research Report 2017
    Published: 08-Dec-2017        Price: US 3400 Onwards        Pages: 102
    The global Sexual Enhancement Supplements market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Sexual Enhancement Supplements development status and future trend in China, focuses on top players in Chi......
  • Global Polio Vaccines Market Professional Survey Report 2017
    Published: 08-Dec-2017        Price: US 3500 Onwards        Pages: 104
    This report studies Polio Vaccines in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Astellas Pharma - CSL - Emergent BioSolutions - GlaxoSmithKline......
  • Global Measle Vaccine Sales Market Report 2017
    Published: 08-Dec-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Measle Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Measle Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs